During the past decade, Central Florida Endocrine & Diabetes Consultants conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Florida Endocrine & Diabetes Consultants" #1 collaborator was "Mylan GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Central Florida Endocrine & Diabetes Consultants" are "Acromegaly" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Central Florida Endocrine & Diabetes Consultants" in a lesser frequency.

Most popular intervention types in "Central Florida Endocrine & Diabetes Consultants" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "FlexPen NovoLog®" (1 trials), "MYL-1601D Product" (1 trials) and "Pasireotide long acting release formulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Florida Endocrine & Diabetes Consultants" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Central Florida Endocrine & Diabetes Consultants". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Central Florida Endocrine & Diabetes Consultants, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Florida Endocrine & Diabetes Consultants, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".